Genomics BioSci & Tech.Ltd Balance Sheet Health
Financial Health criteria checks 3/6
Genomics BioSci & Tech.Ltd has a total shareholder equity of NT$765.5M and total debt of NT$268.9M, which brings its debt-to-equity ratio to 35.1%. Its total assets and total liabilities are NT$1.1B and NT$368.3M respectively.
Key information
35.1%
Debt to equity ratio
NT$268.87m
Debt
Interest coverage ratio | n/a |
Cash | NT$253.03m |
Equity | NT$765.51m |
Total liabilities | NT$368.33m |
Total assets | NT$1.13b |
Recent financial health updates
No updates
Recent updates
Is Genomics BioSci & Tech. Co.,Ltd.'s (GTSM:4195) 7.2% Dividend Worth Your Time?
Apr 27Key Things To Consider Before Buying Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) For Its Dividend
Jan 19Genomics BioSci & Tech. Co.,Ltd. (GTSM:4195) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Nov 25Financial Position Analysis
Short Term Liabilities: 4195's short term assets (NT$471.8M) exceed its short term liabilities (NT$146.1M).
Long Term Liabilities: 4195's short term assets (NT$471.8M) exceed its long term liabilities (NT$222.2M).
Debt to Equity History and Analysis
Debt Level: 4195's net debt to equity ratio (2.1%) is considered satisfactory.
Reducing Debt: 4195's debt to equity ratio has increased from 8.3% to 35.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 4195 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 4195 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.